Aclarion, Inc. Common Stock

Go to Aclarion, Inc. Common Stock Website

$7.40

0.40 (5.71%)
Live
Previous Close

$7

Day Range

$7.0001 - $7.42

Previous Day Range

$6.8157 - $7.1321

Market Cap

$4.1 million USD

Day Vol.

16003

Previous Day Vol.

12437

Currency

USD

Primary Exchange

Nasdaq

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Aclarion, Inc. announced the first patient enrollment in the CLARITY trial, a randomized clinical trial designed to demonstrate Nociscan's ability to improve surgical outcomes for chronic low back pain. The trial will enroll 300 patients at multiple high-volume sites across the US.

Related tickers: ACON, ACONW.

Read Full Article

Aclarion, a healthcare technology company, announced that renowned spine surgeon Dr. Kris Radcliff will present the company's NOCISCAN platform at the upcoming State of Spine Surgery Think Tank. NOCISCAN is an AI-based platform that helps physicians identify the location of chronic low back pain.

Related tickers: ACON, ACONW.

Read Full Article
Trending Tickers

Please sign in to view